MedPath

The TransEnterix European Patient Registry

Recruiting
Conditions
Surgery
Registration Number
NCT03385109
Lead Sponsor
Asensus Surgical
Brief Summary

An open label observational registry trial in which participating centers enroll subjects who had or will have a laparoscopically assisted surgery using the Senhance Surgical System.

Detailed Description

This is a prospective multi-center registry in which sites may also choose to retrospectively enroll subjects meeting the inclusion criteria, but whom have already been treated using the Senhance system. The data collection includes baseline patient characteristics, surgical details, and adverse events. Patient follow-up time point is open to the clinical practice of each center and only adverse events are tracked post discharge.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  • patients 18-80 years old
  • Signed the informed consent
  • life expectancy 12 months or more
Exclusion Criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adverse EventSurgery to 30 days post op

Any untoward sign symptom or disease

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

St. Marien-Krankenhaus

🇩🇪

Siegen, Germany

St. Marien-Krankenhaus
🇩🇪Siegen, Germany
Frank Willeke, MD
Contact
+44 0271 231 1509
f.willeke@marienkrankenhaus.com
Dietmar Stephan, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.